Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1974 3
1979 1
1980 2
1981 1
1982 4
1983 7
1984 6
1985 8
1986 3
1987 5
1988 8
1989 9
1990 7
1991 2
1992 2
1993 5
1994 4
1995 3
1996 9
1997 8
1998 4
1999 9
2000 5
2001 3
2002 5
2003 11
2004 12
2005 17
2006 13
2007 9
2008 11
2009 10
2010 12
2011 11
2012 11
2013 16
2014 17
2015 14
2016 10
2017 9
2018 8
2019 6
2020 7
2021 6
2022 14
2023 12
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

344 results

Results by year

Filters applied: . Clear all
Page 1
Effects of Geriatric Interdisciplinary Home Rehabilitation on Independence in Activities of Daily Living in Older People With Hip Fracture: A Randomized Controlled Trial.
Karlsson Å, Lindelöf N, Olofsson B, Berggren M, Gustafson Y, Nordström P, Stenvall M. Karlsson Å, et al. Among authors: olofsson b. Arch Phys Med Rehabil. 2020 Apr;101(4):571-578. doi: 10.1016/j.apmr.2019.12.007. Epub 2020 Jan 11. Arch Phys Med Rehabil. 2020. PMID: 31935353 Free article. Clinical Trial.
Cyclopropenium functionalization.
Doobary S, Olofsson B. Doobary S, et al. Among authors: olofsson b. Nat Chem. 2024 May 23. doi: 10.1038/s41557-024-01541-w. Online ahead of print. Nat Chem. 2024. PMID: 38783039 No abstract available.
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.
Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K; CHARM Investigators and Committees. Granger CB, et al. Among authors: olofsson b. Lancet. 2003 Sep 6;362(9386):772-6. doi: 10.1016/S0140-6736(03)14284-5. Lancet. 2003. PMID: 13678870 Clinical Trial.
Current biology of VEGF-B and VEGF-C.
Olofsson B, Jeltsch M, Eriksson U, Alitalo K. Olofsson B, et al. Curr Opin Biotechnol. 1999 Dec;10(6):528-35. doi: 10.1016/s0958-1669(99)00024-5. Curr Opin Biotechnol. 1999. PMID: 10600689 Review.
Vascular endothelial growth factors VEGF-B and VEGF-C.
Joukov V, Kaipainen A, Jeltsch M, Pajusola K, Olofsson B, Kumar V, Eriksson U, Alitalo K. Joukov V, et al. Among authors: olofsson b. J Cell Physiol. 1997 Nov;173(2):211-5. doi: 10.1002/(SICI)1097-4652(199711)173:2<211::AID-JCP23>3.0.CO;2-H. J Cell Physiol. 1997. PMID: 9365524 Review. No abstract available.
Explaining Regiodivergent Vinylations with Vinylbenziodoxolones.
Di Tommaso EM, Norrby PO, Olofsson B. Di Tommaso EM, et al. Among authors: olofsson b. Angew Chem Int Ed Engl. 2022 Aug 22;61(34):e202206347. doi: 10.1002/anie.202206347. Epub 2022 Jul 8. Angew Chem Int Ed Engl. 2022. PMID: 35748793 Free PMC article.
344 results